Associate Prof. Deyarina Gonzalez

Gwenin - Applied Research in Chemistry and Public Health (ARCH)

Associate Prof Deyarina Gonzalez

Associate Prof. Deyarina Gonzalez

Swansea University

Contact details

Telephone +44 (0)1792 295384


Deya’s research focuses on gene expression and function in the uterus and its relationship to fertility and cancer. Her clinical interests are Polycystic Ovary Syndrome (PCOS), endometriosis, unexplained infertility and gynaecological cancers (endometrial, ovarian and cervical cancer). She has strategic collaborations with clinicians at Abertawe Bro Morgannwg University NHS health board, developing cellular and molecular approaches to determine mechanisms underlying gynaecological pathologies, to identify biomarkers. Her projects on endometrial implantation and differentiation, relate to L-selectin ligands (MUC1), hormone nuclear receptors and WT1 pathway. Her research in gynaecological cancer includes the regulation of tamoxifen target genes in endometrium and new methods to identify biomarkers for pre-disposition of infertile women to develop gynaecological cancers. Her aim is to translate basic research into clinically relevant observations for patient benefit. Her projects involve collaboration with the private sector to expedite validation of clinical diagnostic biomarkers and the development of new drug leads for targeted cancer therapy. She also has multidisciplinary collaborations in the area of nanosensors and improved performance medications in the field of human reproductive biology and hormone therapy. She has received research grants valuing over £1m in the recent years.

Deya has published more than 20 articles during her career on human, animal, plant and yeast research. She is a member of the Endocrine Society and acts as an expert reviewer for Journal of Clinical Endocrinology and Metabolism, Human Reproduction and others. She teaches within the Genetics & Biochemistry (College of Medicine) and Biomedical Engineering (College of Engineering) undergraduate programmes.

About research group

Reproductive biology and gynaecological oncology research in Swansea covers basic and translational research into uterine pathologies including endometrial cancer, poly-cystic ovary syndrome, endometriosis and unexplained infertility linked to endometrial (the lining of the womb) dysfunction. More recently new research has been established in the areas of ovarian cancer, ovarian reserve and overactive bladder syndrome. Our research involves the study of cell signalling, nanobiology, transcription and epigenetics, the development of clinically relevant biomarkers, and the development of therapeutic interventions. Our group works closely with clinicians in the Departments of Obstetrics and Gynaecology, and Pathology, in the Abertawe Bro Morgannwg University Health Board in Singleton Hospital, Swansea, and The Princess of Wales Hospital in Bridgend.


Presentation title:

Antibody Drug Conjugates for gynaecological cancers.



Antibody drug conjugates (ADCs) combine the specificity of antibodies with the potency of small molecule cytotoxic drugs. This presentation will give an overview about the current state of  ADC development. A novel ADC developed by Swansea University as a potential therapeutic for the treatment of gynaecological cancers will be discussed in more detail and latest results will be presented. The evaluation of  ADCs activity using screening platforms will be discussed.

Please click to logos to go back to the agenda

NRN workshop logos

Back to top

Gwenin - Applied Research in Chemistry and Public Health (ARCH)

School of Chemistry, Bangor University, Bangor, Gwynedd, LL57 2UW, UK

Direct Line: 0044 1248 383741   email:

Gwenin - Applied Research in Chemistry and Public Health (ARCH)


News: February 2020

Swansea University announces CALIN 11Picture1€5 million of additional funding announced for Ireland-Wales innovation project that is driving life science sector growth across the two countries.

News: December 2019

jos.jpgCongratulations to Josh for passing his MRes

News: December 2019

towerDr. Gwenin leaves Bangor

News: November 2019

P1000779Congratulations to Pat on passing his PhD